Amid the Covid-19 crisis, Operation Warp Speed helped to develop vaccines with astonishing speed. But even with a fast-tracked FDA process, there still remain significant questions about risk, liability, and intellectual property. These are the subjects of two new Gray Center working papers by Professors Sam Halabi of the University of Missouri and Professor Kristen Osenga of the University of Richmond. The papers were discussed at a roundtable last fall, and published as working papers this year. In this episode of the podcast, they join Adam to discuss their papers and what we’ve learned since the fall. (NOTE: Unfortunately, we encountered some audio difficulties during the recording).

This episode features Sam Halabi, Kristen Osenga, and Adam White.

Subscribe to Gray Matters in Apple Podcasts (and leave a 5-star review, please!), or by RSS feed. For all our podcasts in one place, subscribe to the Ricochet Audio Network Superfeed in Apple Podcasts or by RSS feed.